Gastroenterology and Hepatology - Issue 5/2023

Editorial

371

Colorectal cancer screening in the Czech Republic

Štěpán Suchánek

374

Editorial

M. Huorka

Quiz

381

Anemic patient

M. Bortlík

Gastrointestinal Oncology: Original Article

385

Results from the evaluation of colorectal cancer screening in the Czech Republic

O. Ngo, R. Chloupková, Štěpán Suchánek, M. Ambrožová, Hejcmanová K., P. Dvořák, Miroslav Zavoral, K. Hejduk, L. Dušek, O. Májek

394

Trends in premature mortality from digestive system cancers in Slovakia in the years 2011–2020: 8 diagnoses over 10 years

T. Koller, A. Baráková

Gastrointestinal Oncology: Case Report

409

Mixed adenoneuroendocrine carcinoma of the stomach – a case report

M. Drab, E. Tomsová, J. Marček, T. Klinger

IDB: Original Article

419

Subcutaneous infliximab in the treatment of refractory Crohn‘s disease patients – a pilot study of drug immunogenicity

Karin Černá, D. Ďuricová, M. Lukáš, N. Machková, V. Hrubá, K. Kaštylová, K. Mitrová, M. Kostrejová, K. Kubíčková, Š. Peterka, M. Kolář, J. Jirsa, G. Vojtěchová, M. Lukáš

IBD: Guidelines

427

Konsenzus Pracovnej skupiny pre IBD Slovenskej gastroenterologickej spoločnosti

L. Gombošová, Z. Zelinková, B. Kadlečková, P. Lietava, M. Greguš, E. Barlová, L. Novotná

IBD: Review Article

437

Urolithiasis in patients with inflammatory bowel disease – possibilities of prevention and metabolic influence

V. Teplan, R. Netušil, M. Lukáš

447

The selection from international journals

449

Anniversary of Prof. Miroslav Zavoral, MD, PhD.

452

Current possibilities of using tofacitinib in ulcerative colitis in domestic practice

461

Registry – okno do skutečného světa klinické praxe

462

Nejdůležitějším cílem je kvalita života

455

Subcutaneous infliximab – treatments and new possibilities after clinical practice

459

Desired IBD treatment goals and how to achieve them

466

Kreditovaný autodidaktický test: Gastrointestinální onkologie

Gastroenterology and Hepatology

2023 Issue 5